Tilray Brands, Inc. (TLRY) Financials

TLRY Assets vs Liabilities
DateAssetsLiabilities
Feb. 28, 2026 2.1 billion 549.1 million
Nov. 30, 2025 2.9 billion 771.3 million
Aug. 31, 2025 2.9 billion 772.0 million
May 31, 2025 2.9 billion 860.5 million

TLRY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Feb. 28, 2026 -21.9 million 13.7 million
Nov. 30, 2025 -25.5 million 17.2 million
Aug. 31, 2025 -14.9 million 6.9 million
May 31, 2025 -29.3 million 6.1 million

TLRY Net Income

No data available :(

TLRY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Feb. 28, 2026 219.9 million 195.3 million -
Nov. 30, 2025 407.3 million 314.3 million 96.6 million
Aug. 31, 2025 363.8 million 313.8 million 97.3 million
May 31, 2025 351.8 million 322.4 million 89.1 million

TLRY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Feb. 28, 2026 ?
Nov. 30, 2025 110.3 million
Aug. 31, 2025 106.0 million
May 31, 2025 97.8 million

TLRY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Feb. 28, 2026 - - 60.8 million 10.6 million
Nov. 30, 2025 13.5 million 108964 102.1 million 30.4 million
Aug. 31, 2025 13.1 million 56319 88.4 million 31.7 million
May 31, 2025 9.4 million 46654 81.7 million 31.9 million

TLRY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Feb. 28, 2026 206.7 million 151.8 million
Nov. 30, 2025 303.9 million 223.5 million
Aug. 31, 2025 287.8 million 208.8 million
May 31, 2025 308.1 million 215.3 million

TLRY Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TLRY

Price: $5.19

52 week price:
3.50
23.20

Earnings Per Share: -14.63 USD

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Canada

Volume: 12.7 million

Market Capitalization: 691.9 million

Links: